RCANN
LIVE

Serial Number

88637042

Owner

Jay Pharma, Inc.

Attorney

Richard M. Klein

Filing Date

Sep 30, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RCANN Trademark

Serial Number: 88637042

RCANN is a trademark filed by Jay Pharma, Inc. on September 30, 2019. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Jay Pharma, Inc. (5 trademarks)

Suite 200
Naples, FL 34103

Entity Type: 03

AKOS BIOSCIENCES, INC. (4 trademarks)

NAPLES, FL 34103

Entity Type: 03

Trademark Details

Filing Date

September 30, 2019

Registration Date

Not Registered

Goods & Services

cannabidiol oil for medical and therapeutic purposes; cannabis oil for therapeutic purpose; cannabis oil for the treatment of cancer; medicinal cannabis for the relief of nerve pain, nausea, and muscle spasms; antibiotic ointments; anti-inflammatory ointments; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; transdermal patches for use in the treatment of cancer, for the relief of nerve pain, nausea, sleep and appetite; medicinal cannabis for the aid to sleep; skin ointment to treat radio-dermatitis; cannabis and CBD based oils, creams, ointments, capsules and patches for treatment of medical and therapeutic issues; any CBD in the goods being either synthetic CBD or CBD solely derived from hemp or other natural products, and with a delta-9 tetrahdyrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

cannabidiol skin and body oil for cosmetic purposes; cannabis skin and body oil for cosmetic purposes; bath oil; essential oil for personal use; facial oil; skin cream; aromatic oil; terpenes as essential oil; cannabis and CBD based oils, creams, ointments, capsules and patches for treatment of cosmetic issues; any CBD in the goods being either synthetic CBD or CBD solely derived from hemp or other natural products, and with a delta-9 tetrahdyrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 5, 2026 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 31, 2026 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 29, 2025 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 14, 2025 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 28, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 28, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jan 28, 2025 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 29, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 11, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 11, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 11, 2023 CNSL
ASSIGNED TO EXAMINER
Dec 4, 2023 DOCK
ASSIGNED TO EXAMINER
Nov 25, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 10, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 16, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 16, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 16, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 7, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 7, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 7, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 31, 2023 ERSI
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 5, 2022 ASGN
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 10, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 10, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 10, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 10, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 10, 2022 GNSL
SUSPENSION LETTER WRITTEN
Feb 10, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2022 CRFA
ASSIGNED TO LIE
Jan 26, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 22, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 2, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 2, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 2, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 25, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 25, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jan 25, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 16, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 16, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 16, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 14, 2020 DOCK
ASSIGNED TO EXAMINER
Jun 11, 2020 DOCK
ASSIGNED TO EXAMINER
Oct 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2019 NWOS
NEW APPLICATION ENTERED
Oct 3, 2019 NWAP